Biotech startup developing therapies that match molecules in human milk withdraws IPO filing

A quiet Seattle biotech company, Intrinsic Medicine, filed to go public in April but withdrew its plans yesterday, according to a regulatory filing. Intrinsic Medicine is developing sugar-based molecules matching… Read More